Grants for Private institutions of higher education - Health

The Artistic Legacy Grant (ALG), funded by the San Francisco Arts Commission, offers $10,000 to $100,000 for a 3-year period to support and celebrate an artist who has significantly contributed to San Francisco's arts and culture for at least 25 years, with funds to be used for professional development, artistic planning, sabbaticals, and other related costs.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine to treat neurological diseases, aiming to advance health and wellness for residents through innovative, collaborative projects.

This grant provides financial support to nonprofit organizations and agencies that enhance the quality of life for older adults in Franklin County and the Central Pennsylvania region.

This funding opportunity supports research institutions and organizations in studying biological markers of cognitive decline and dementia in aging individuals with Autism Spectrum Disorders, aiming to improve understanding and assessment of these conditions.

This funding opportunity provides financial support to nonprofit organizations, government entities, and educational institutions in Ohio to enhance and sustain trauma-informed care initiatives across six designated regions.

This funding opportunity provides financial support for short-term projects that enhance local governance, infrastructure, education, and public safety in U.S. territories and freely associated states.

This funding opportunity provides financial support to organizations in Illinois to establish a peer-staffed phone line that offers free, confidential emotional support and resources for individuals facing mental health challenges.

This funding opportunity is designed for healthcare institutions and organizations in the U.S. to improve the management and outcomes of migraine patients in emergency departments.

Wastewater Based Epidemiology involves analyzing the chemical and biological components present in wastewater to gather information about the health and behavior of a population. Localities have used it to monitor drug consumption patterns in their communities and understand local drug usage trends. It holds promise for monitoring the emergence and geographic distribution of novel substances often referred to as emerging threats. In FY2023, the United States Government funded pilot WBE drug projects that collected wastewater samples in over 70 United States communities representing tens of millions of Americans. The samples were analyzed for parent drugs, such as fentanyl and methamphetamine, and metabolites. Researchers shared results with participating sampled communities, local and state partners, and to a limited extent, the government sponsors.

This funding opportunity provides financial support to organizations working to combat domestic violence, dating violence, sexual assault, and stalking in rural communities across the U.S.

This funding opportunity provides financial support for innovative projects that aim to improve the development of treatments for ultra-rare cancers, targeting both pediatric and adult populations, and is open to a variety of U.S.-based organizations and institutions.

This grant provides researchers access to valuable biospecimens and data from a national health initiative to conduct large-scale studies that advance precision medicine and improve understanding of health outcomes.

This grant provides funding to rural organizations to improve and expand services for preventing and treating opioid use disorder, ensuring sustainable support for affected communities.

This funding opportunity provides financial support to a variety of organizations to help strengthen Botswana's health data systems and public health responses to HIV, tuberculosis, and other health threats.

This funding opportunity is designed to support the establishment of collaborative research centers that enhance the study and treatment of bone, muscle, and orthopaedic conditions through shared resources and multidisciplinary approaches.

This funding opportunity provides financial support to community organizations and institutions to improve awareness and participation in lupus clinical trials among underrepresented populations, particularly racial and ethnic minorities and women of childbearing age.

The Pfizer Sickle Cell Disease (SCD) Fellowship Grant is designed to bolster the number of fellowship programs focused on hematologists who specialize in the treatment of adults with sickle cell disease. This initiative is part of Pfizer Global Medical Grants' broader strategy to support healthcare community-led initiatives that enhance patient outcomes in critical areas of unmet medical need, aligning with Pfizer’s own medical and scientific strategies. The grant aims to enhance the quality of care for sickle cell patients by funding institutions that provide comprehensive training and research opportunities in the field. Specifically, the program supports both established and newly developed fellowship programs that include a robust curriculum in clinical practice, independent research, and education to deepen the scientific understanding of SCD. The fellowship is structured to foster an environment of expert mentorship and significant independent research opportunities. Research activities encouraged under this grant include observational studies and outcomes research that focus on the disease itself, screening tools, and their impact on patient health improvement. Grant funding is set at a maximum of $100,000 for a one-year fellowship, aiming to cover direct costs associated with the fellow’s training and research but explicitly excluding overhead or indirect costs. This financial support underlines Pfizer's commitment to advancing healthcare by investing directly in the development of professionals who are dedicated to improving patient outcomes in the field of sickle cell disease. Key to the grant’s operational framework is compliance with stringent regulatory requirements, including the U.S. Physician Payments Sunshine Act. This act mandates detailed reporting of all transfers of value to ensure transparency and maintain public trust in healthcare practices. The fellowship’s funding structure is designed to be transparent, with specific provisions to prevent any of the funds from benefiting Pfizer's business interests directly or indirectly. Overall, the Pfizer SCD Fellowship embodies a strategic effort to cultivate talent and advance knowledge in a critical area of healthcare, ensuring that the supported programs maintain high standards of integrity and contribute significantly to the field's body of knowledge and patient care practices.

This ISO seeks solution summary and proposal submissions for projects that fall within the scope of the ARPA-H mission Resilient Systems Office (RSO). RSOs interest areas will address systemic challenges across the healthcare and public health landscape by investing in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care.Aspects of todays health and public health systems remain fragile due to systemic challenges, which include rising healthcare costs, inadequate healthcare coverage for significant populations, outdated infrastructure, and health disparities among different demographic groups. Acute challenges, such as hospital closures, supply chain disruptions, staffing shortages, cyber-attacks, public health crises, and the emergence of new diseases, further exacerbate existing fragilities, making it more difficult to maintain high standards of care. These challenges are compounded by the fact that systems remain fragmented, hindering the ability to gain comprehensive insights, make informed decisions, develop tailored interventions, and share critical health information between stakeholders.RSO seeks solution summaries and proposals that drive innovations to enhance the adaptability, reliability, and interoperability of the health ecosystem. Of interest are innovations that foster flexibility and enable adaptation to system stressors, so that people and systems remain well-positioned to deliver high-quality care and improve health outcomes. The following interest areas categorize the ground-breaking research we seek to support:Sociotechnical System Innovation: Innovate user-centric digital health tools, platforms, technologies, and intervention models that improve outcomes across the health continuum, including prevention, diagnosis, and treatment of physical, mental, and behavioral health. Approaches to build trust in the healthcare system and distribute high-quality health guidance in an understandable manner that improves patient outcomes. Novel real-time measurement tools to track health outcomes, evaluate post-market performance of new interventions, and enable convergence on the most effective strategies to improve the quality of care, especially for underserved communities. Other population centered innovations to create more resilient communities and subpopulations. Innovations might include aggregate improvements to quality of care and better physical, mental, and behavioral health outcomes for the health ecosystem.Health Ecosystem Integration: Novel ways to collect, protect, secure, integrate, analyze, communicate, and present health data, including but not limited to advances in privacy, cyber security, artificial intelligence with enhanced patient safety properties, low-code or no-code technologies, semantic approaches, and rapid integration techniques. Strategies and technologies to leverage homes, community centers, pharmacies, and other accessible locations to enable new modalities of high-quality care, expand the reach of clinical research, or integrate end-user feedback to rapidly iterate prototype designs. Approaches to strengthen the connectivity and interoperability of health data and devices to 5 enable the safe, secure, and seamless exchange of information among healthcare providers, researchers, and stakeholders. Other novel approaches to increase the interoperability of health-related systems in support of improved health outcomes and enhanced transparency across the health ecosystem.Adaptive Antifragile Solutions: Creative approaches to enhance the stability and dependability of the health ecosystem through new adaptive paradigms, methods that anticipate and mitigate disruptions before they occur, and enhancements to emergency response. Approaches that enable health infrastructure to rapidly integrate information from new sensors; create decision support tools; adapt supply chains, manufacturing, and logistics; and better leverage the workforce during public health emergencies. Novel methods to engineer resilient tissues, microbiomes, and biophysical systems to combat disease or maintain health. Other novel approaches to enhance adaptability and reduce fragility within the health ecosystem.Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, systems, or methodology. Specifically excluded are proposals that represent an evolutionary or incremental advance in the state of the art or technology that has reached the clinical trial stage. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission

This grant provides funding for U.S.-based organizations to develop independent educational programs that improve healthcare professionals' understanding of maintenance therapy in patients with HER2-positive metastatic breast cancer.

This funding opportunity provides financial support to organizations focused on improving mental health and care engagement for individuals living with HIV, particularly those facing barriers to treatment.